71 – 80 of 382
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
- Contribution to journal › Article
-
Mark
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
- Contribution to journal › Article
-
Mark
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.
- Contribution to journal › Article
-
Mark
Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system
- Contribution to journal › Article
-
Mark
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
- Contribution to journal › Article
-
Mark
Non-Hodgkin lymphoma in familial amyloid polyneuropathy patients in Sweden
- Contribution to journal › Letter
-
Mark
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
- Contribution to journal › Article
